Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE:003020), Hefei Xinchen Enterprise Management Consulting Co., Ltd., Li Chao and Deng Xiaojuan agreed to acquire Hefei Noratech Pharmaceuticals Co., Ltd. from Roaring Success Ltd and Hefei Xinchen Enterprise Management Consulting Co., Ltd. for CNY 72 million on October 29, 2023. As of June 30, 2023, Hefei Noratech Pharmaceuticals Co., Ltd. generated total assets of CNY 136.3 million and net assets of CNY 75.7 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 CNY | -4.58% | -8.12% | -20.92% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.92% | 489M | |
+51.99% | 798B | |
+41.38% | 633B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.87% | 244B | |
+3.15% | 227B | |
+11.01% | 216B | |
+7.59% | 166B |
- Stock Market
- Equities
- 003020 Stock
- News Hefei Lifeon Pharmaceutical Co., Ltd.
- Hefei Lifeon Pharmaceutical Co., Ltd., Hefei Xinchen Enterprise Management Consulting Co., Ltd., Li Chao and Deng Xiaojuan agreed to acquire Hefei Noratech Pharmaceuticals Co., Ltd. from Roaring Success Ltd and Hefei Xinchen Enterprise Management Consulting Co., Ltd. for CNY 72 million.